RPC1063 (equivalent to ozanimod HCl)

( DrugBank: Ozanimod / KEGG DRUG: Ozanimod )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	73

96. クローン病

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

trials per page:

Showing 1 to 10 of 73 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2017-004294-14-FR (EUCTR)	02/12/2019	09/02/2018	Multicenter Study of Oral Ozanimod as Maintenance Therapy in patients with Moderately to Severely Ac ...	A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Maint ...	Moderately to Severely Active Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 100 ...	Product Name: ozanimod Product Code: RPC1063 (equivalent to ozanimod HCl) INN or Proposed INN: Ozanimo ...	Celgene International II Sàrl	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	535	Phase 3	Belarus;Portugal;Taiwan;Hong Kong;Slovakia;Greece;Ukraine;Italy;France;Puerto Rico;Denmark;Latvia;Mo ...
2	EUCTR2017-004293-33-FR (EUCTR)	12/11/2019	09/02/2018	Multicenter Study of Oral Ozanimod as Induction Therapy in patients with Moderately to Severely Acti ...	Induction Study #2 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of O ...	Moderately to Severely Active Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 100 ...	Product Name: ozanimod Product Code: RPC1063 (equivalent to ozanimod HCl) INN or Proposed INN: Ozanimo ...	Celgene International II Sàrl	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	675	Phase 3	Serbia;Portugal;United States;Saudi Arabia;Hong Kong;Slovakia;Greece;Spain;Ukraine;Russian Federatio ...
3	EUCTR2017-004292-31-FR (EUCTR)	05/11/2019	09/08/2019	Multicenter Study of Oral Ozanimod as Induction Therapy in patients with Moderately to Severely Acti ...	Induction Study #1 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of O ...	Moderately to Severely Active Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 100 ...	Product Name: ozanimod Product Code: RPC1063 (equivalent to ozanimod HCl) INN or Proposed INN: Ozanimo ...	Celgene International II Sàrl	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	675	Phase 3	Belarus;United States;Taiwan;Spain;Ukraine;Ireland;Russian Federation;Israel;Switzerland;Italy;Franc ...
4	EUCTR2017-004295-55-FR (EUCTR)	08/10/2019	09/02/2018	Multicenter Extension Study of Oral Ozanimod in patients with Moderately to Severely Active Crohn’s ...	A Phase 3, Multicenter, Open-Label Extension Study of Oral Ozanimod for Moderately to Severely Activ ...	Moderately to Severely Active Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 100 ...	Product Name: ozanimod Product Code: RPC1063 (equivalent to ozanimod HCl) INN or Proposed INN: Ozanimo ...	Celgene International II Sàrl	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	1350	Phase 3	Belarus;Portugal;Taiwan;Hong Kong;Slovakia;Greece;Ukraine;Italy;France;Puerto Rico;Denmark;Latvia;Mo ...
5	EUCTR2017-004294-14-RO (EUCTR)	11/04/2019	12/05/2022	Multicenter Study of Oral Ozanimod as Maintenance Therapy in patients with Moderately to Severely Ac ...	A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Maint ...	Moderately to Severely Active Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 100 ...	Product Name: ozanimod Product Code: RPC1063 (equivalent to ozanimod HCl) INN or Proposed INN: Ozanimo ...	Celgene International II Sàrl	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	485	Phase 3	Belarus;Portugal;Taiwan;Hong Kong;Slovakia;Greece;Ukraine;Italy;France;Puerto Rico;Denmark;Latvia;Mo ...
6	EUCTR2017-004292-31-RO (EUCTR)	04/02/2019	25/02/2022	Multicenter Study of Oral Ozanimod as Induction Therapy in patients with Moderately to Severely Acti ...	Induction Study #1 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of O ...	Moderately to Severely Active Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 100 ...	Product Name: ozanimod Product Code: RPC1063 (equivalent to ozanimod HCl) INN or Proposed INN: Ozanimo ...	Celgene International II Sàrl	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	600	Phase 3	United States;Belarus;Taiwan;Spain;Ukraine;Ireland;Russian Federation;Israel;Switzerland;Italy;Franc ...
7	EUCTR2017-004295-55-PT (EUCTR)	04/02/2019	01/10/2018	Multicenter Extension Study of Oral Ozanimod in patients with Moderately to Severely Active Crohn’s ...	A Phase 3, Multicenter, Open-Label Extension Study of Oral Ozanimod for Moderately to Severely Activ ...	Moderately to Severely Active Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 100 ...	Product Name: ozanimod Product Code: RPC1063 (equivalent to ozanimod HCl) INN or Proposed INN: Ozanimo ...	Celgene International II Sàrl	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	1200	Phase 3	Portugal;Belarus;Hong Kong;Taiwan;Slovakia;Greece;Ukraine;Italy;France;Puerto Rico;Denmark;Latvia;Mo ...
8	EUCTR2017-004295-55-BE (EUCTR)	13/12/2018	30/03/2018	Multicenter Extension Study of Oral Ozanimod in patients with Moderately to Severely Active Crohn’s ...	A Phase 3, Multicenter, Open-Label Extension Study of Oral Ozanimod for Moderately to Severely Activ ...	Moderately to Severely Active Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 100 ...	Product Name: ozanimod Product Code: RPC1063 (equivalent to ozanimod HCl) INN or Proposed INN: Ozanimo ...	Celgene International II Sàrl	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	1200	Phase 3	Belarus;Portugal;Hong Kong;Taiwan;Slovakia;Greece;Ukraine;Italy;France;Puerto Rico;Denmark;Latvia;Mo ...
9	EUCTR2017-004294-14-DK (EUCTR)	30/11/2018	27/08/2018	Multicenter Study of Oral Ozanimod as Maintenance Therapy in patients with Moderately to Severely Ac ...	A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Maint ...	Moderately to Severely Active Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 100 ...	Product Name: ozanimod Product Code: RPC1063 (equivalent to ozanimod HCl) INN or Proposed INN: Ozanimo ...	Celgene International II Sàrl	NULL	Not Recruiting			Female: yes Male: yes	535	Phase 3	Belarus;Portugal;Taiwan;Hong Kong;Slovakia;Greece;Ukraine;Italy;France;Puerto Rico;Denmark;Latvia;Mo ...
10	EUCTR2017-004295-55-DK (EUCTR)	30/11/2018	27/08/2018	Multicenter Extension Study of Oral Ozanimod in patients with Moderately to Severely Active Crohn’s ...	A Phase 3, Multicenter, Open-Label Extension Study of Oral Ozanimod for Moderately to Severely Activ ...	Moderately to Severely Active Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 100 ...	Product Name: ozanimod Product Code: RPC1063 (equivalent to ozanimod HCl) INN or Proposed INN: Ozanimo ...	Celgene International II Sàrl	NULL	Not Recruiting			Female: yes Male: yes	1350	Phase 3	Belarus;Portugal;Taiwan;Hong Kong;Slovakia;Greece;Ukraine;Italy;France;Puerto Rico;Denmark;Latvia;Mo ...

First Previous1 2 3 4 5…8Next Last